Treatment Induced Autophagy Associated with Tumor Dormancy and Relapse

Abstract

Studies were performed to identify the nature of chemotherapy (and radiation) induced autophagy in the MMC breast tumor cell line and the 4T1 breast tumor cell line, both of which are syngeneic and can be grown in immune competent mice. We found that the autophagy induced in the 4t1 cells was nonprotective in that its inhibition by pharmacological or genetic approaches failed to alter sensitivity to chemotherapy or radiation. In contrast, autophagy in the MMC cells was clearly cytoprotective. These differences may be related to the p53 status of the tumor cells, as the 4T1 cells are p53 null while the MMC cells are wild-type in p53.It is generally perceived that interference with autophagy will enhance sensitivity to chemotherapy and radiation; however, this premise applies solely when the autophagy is protective. Sine mutations inp53 are common in breast cancer as well as other malignancies, having a p53 null cell line may be more relevant to clinical breast cancer than ap53 wt line.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2016
Accession Number
AD1019633

Entities

People

  • David A. Gewirtz

Organizations

  • Virginia Commonwealth University

Tags

DTIC Thesaurus Topics

  • Autophagy
  • Biological Aging
  • Breast Cancer
  • Cell Line
  • Cell Physiological Processes
  • Chemotherapy
  • Diseases And Disorders
  • Immune System
  • Inhibition
  • Ionizing Radiation
  • Medical Personnel
  • Neoplasms
  • Programmed Cell Death
  • Radiation
  • Recovery
  • Therapy
  • Tumor Cell Line

Fields of Study

  • Biology
  • Medicine

Readers

  • Molecular and Cellular Biology
  • Oncology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech